|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenue: | |||||
| Premiums and policy fees | |||||
| Ceded reinsurance premiums and policy fees | |||||
| Net investment income | |||||
| Other income | |||||
| Revenue before net investment gains (losses) | |||||
| Net investment gains (losses): | |||||
| Other-than-temporary impairments | |||||
| Other realized investment gains, net | |||||
| Change in fair value of equity securities | |||||
| Total net investment gains | |||||
| Total revenues | |||||
| Benefits and other expenses: | |||||
| Benefits, claims and settlement expenses: | |||||
| Life | |||||
| Ceded reinsurance benefits and claims | |||||
| Annuity | |||||
| Dividends to policyholders | |||||
| Commissions | |||||
| Amortization of cost of insurance acquired | |||||
| Operating expenses | |||||
| Interest expense | |||||
| Total benefits and other expenses | |||||
| Income before income taxes | |||||
| Income tax expense | |||||
| Net income | |||||
| Net income attributable to noncontrolling interest | |||||
| Net income attributable to common shareholders | |||||
| Amounts attributable to common shareholders: | |||||
| Basic income per share (in dollars per share) | |||||
| Diluted income per share (in dollars per share) | |||||
| Basic weighted average shares outstanding (in shares) | |||||
| Diluted weighted average shares outstanding (in shares) |
Loading...